Optimising prescribing in type 2 diabetes

We will introduce a groundbreaking new tool to help healthcare professionals choose the best medication for glucose- lowering among five major drug class for people with type 2 diabetes. The medications include DPP4- inhibitors, GLP-1 receptor agonists, sulfonylureas, SGLT2- inhibitors, and thiazolidinediones. The tool uses only simple clinical information and routine lab results, making it easy to use in clinical practice. As will be reported in a forthcoming publication in the Lancet, the new model can improve blood sugar control, lower risk of treatment failure, and lower risk of diabetes complications. As we will highlight the model represents  major opportunity to improve the clinical care of people with type 2 diabetes.